The predictive utility of circulating PCSK9 levels on diabetes mellitus.

Peng, Jia; Zhu, Cheng-Gang; Li, Jian-Jun

Peng, Jia; Zhu, Cheng-Gang; Li, Jian-Jun.

Afiliación

Peng J; State Key Laboratory of Cardiovascular Diseases, FuWai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, No 167 BeiLiShi Road, XiCheng District, Beijing, 100037, China.
Zhu CG; State Key Laboratory of Cardiovascular Diseases, FuWai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, No 167 BeiLiShi Road, XiCheng District, Beijing, 100037, China.
Li JJ; State Key Laboratory of Cardiovascular Diseases, FuWai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, No 167 BeiLiShi Road, XiCheng District, Beijing, 100037, China. lijianjun938@126.com.

Cardiovasc Diabetol ; 20(1): 45, 2021 02 13.

Article en En | MEDLINE | ID: mdl-33581713

Asunto(s)

Enfermedad de la Arteria Coronaria; Diabetes Mellitus Tipo 2; Glucemia; Humanos; Proproteína Convertasa 9

Palabras clave

Proprotein convertase subtilisin/kexin type 9; Risks; Type 2 diabetes mellitus

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Diabetes Mellitus Tipo 2 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cardiovasc Diabetol Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google